Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 164309, 8 pages
http://dx.doi.org/10.1155/2014/164309
Review Article

Powering the Immune System: Mitochondria in Immune Function and Deficiency

1Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, 16147 Genova, Italy
3Division of Allergy and Immunology, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, MA 02114, USA
4Novartis Institute for Research in Biomedicine, Basel, Switzerland

Received 16 June 2014; Revised 20 August 2014; Accepted 25 August 2014; Published 21 September 2014

Academic Editor: Luca Gattinoni

Copyright © 2014 Melissa A. Walker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Rossignol, M. Malgat, J. P. Mazat, and T. Letellier, “Threshold effect and tissue specificity. implication for mitochondrial cytopathies,” Journal of Biological Chemistry, vol. 274, no. 47, pp. 33426–33432, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Pagliarini, S. E. Calvo, B. Chang et al., “A mitochondrial protein compendium elucidates complex I disease biology,” Cell, vol. 134, no. 1, pp. 112–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Cogswell, R. J. Stevens, and D. A. Hood, “Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions,” The American Journal of Physiology—Cell Physiology, vol. 264, no. 2, pp. C383–C389, 1993. View at Google Scholar · View at Scopus
  4. J. Chung, C. Chen, and B. H. Paw, “Heme metabolism and erythropoiesis,” Current Opinion in Hematology, vol. 19, no. 3, pp. 156–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. L. Miller, “Steroid hormone synthesis in mitochondria,” Molecular and Cellular Endocrinology, vol. 379, pp. 62–73, 2013. View at Google Scholar
  6. S. B. Vafai and V. K. Mootha, “Mitochondrial disorders as windows into an ancient organelle,” Nature, vol. 491, no. 7424, pp. 374–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Calvo, M. Jain, X. Xie et al., “Systematic identification of human mitochondrial disease genes through integrative genomics,” Nature Genetics, vol. 38, no. 5, pp. 576–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. K. Wagner, T. Kitami, T. J. Gilbert et al., “Large-scale chemical dissection of mitochondrial function,” Nature Biotechnology, vol. 26, no. 3, pp. 343–351, 10.1038/nbt1387.
  9. W. J. H. Koopman, P. H. G. M. Willems, and J. A. M. Smeitink, “Mechanisms of disease: monogenic mitochondrial disorders,” New England Journal of Medicine, vol. 366, pp. 1132–1141, 2012. View at Google Scholar
  10. A. P. West, G. S. Shadel, and S. Ghosh, “Mitochondria in innate immune responses,” Nature Reviews Immunology, vol. 11, no. 6, pp. 389–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Galluzzi, O. Kepp, and G. Kroemer, “Mitochondria: master regulators of danger signalling,” Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 780–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Cloonan and A. M. K. Choi, “Mitochondria: commanders of innate immunity and disease?” Current Opinion in Immunology, vol. 24, no. 1, pp. 32–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Jones and C. B. Thompson, “Revving the engine: signal transduction fuels T cell activation,” Immunity, vol. 27, no. 2, pp. 173–178, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. L. Pearce, M. C. Poffenberger, C. H. Chang, and R. G. Jones, “Fueling immunity: insights into metabolism and lymphocyte function,” Science, vol. 342, no. 6155, Article ID 1242454, 2013. View at Publisher · View at Google Scholar
  15. E. Meylan, J. Curran, K. Hofmann et al., “Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus,” Nature, vol. 437, no. 7062, pp. 1167–1172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. K. Laguna, E. A. Creasey, Z. Li, N. Valtz, and R. R. Isberg, “A Legionella pneumophila-translocated substrate that is required for growth within macrophages and protection from host cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 49, pp. 18745–18750, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. B. Seth, L. Sun, C.-K. Ea, and Z. J. Chen, “Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3,” Cell, vol. 122, no. 5, pp. 669–682, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Hou, L. Sun, H. Zheng, B. Skaug, Q. X. Jiang, and Z. J. Chen, “MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response,” Cell, vol. 146, pp. 448–461, 2011. View at Google Scholar
  19. C. B. Moore, D. T. Bergstralh, J. A. Duncan et al., “NLRX1 is a regulator of mitochondrial antiviral immunity,” Nature, vol. 451, no. 7178, pp. 573–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Tattoli, L. A. Carneiro, M. Jéhanno et al., “NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production,” EMBO Reports, vol. 9, no. 3, pp. 293–300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Arnoult, F. Soaras, I. Tattoli, C. Castanier, D. J. Philpott, and S. E. Girardin, “An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix,” Journal of Cell Science, vol. 122, no. 17, pp. 3161–3168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Lin, S. Paz, and J. Hiscott, “Tom70 imports antiviral immunity to the mitochondria,” Cell Research, vol. 20, no. 9, pp. 971–973, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-M. Boeynaems and D. Communi, “Modulation of inflammation by extracellular nucleotides,” Journal of Investigative Dermatology, vol. 126, no. 5, pp. 943–944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Shi, J. E. Evans, and K. L. Rock, “Molecular identification of a danger signal that alerts the immune system to dying cells,” Nature, vol. 425, no. 6957, pp. 516–521, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Suzuki, A. Mori, K. J. Ishii et al., “Activation of target-tissue immune-recognition molecules by double- stranded polynucleotides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 5, pp. 2285–2290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Scaffidi, T. Misteli, and M. E. Bianchi, “Release of chromatin protein HMGB1 by necrotic cells triggers inflammation,” Nature, vol. 418, article 6894, pp. 191–195, 2002. View at Google Scholar
  27. D. Foell, H. Wittkowski, Z. Ren et al., “Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease,” Journal of Pathology, vol. 216, no. 2, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Zhang, M. Raoof, Y. Chen et al., “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 7285, pp. 104–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, “Thioredoxin-interacting protein links oxidative stress to inflammasome activation,” Nature Immunology, vol. 11, no. 2, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. P. West, I. E. Brodsky, C. Rahner et al., “TLR signalling augments macrophage bactericidal activity through mitochondrial ROS,” Nature, vol. 472, no. 7344, pp. 476–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Lee, M. C. Walsh, K. L. Hoehn, D. E. James, E. J. Wherry, and Y. Choi, “Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity,” Journal of Immunology, vol. 192, pp. 3190–3199, 2014. View at Google Scholar
  32. G. J. W. van der Windt and E. L. Pearce, “Metabolic switching and fuel choice during T-cell differentiation and memory development,” Immunological Reviews, vol. 249, no. 1, pp. 27–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Wang, C. P. Dillon, L. Z. Shi et al., “The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation,” Immunity, vol. 35, no. 6, pp. 871–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. D. Michalek, V. A. Gerriets, A. G. Nichols et al., “Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 45, pp. 18348–18353, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. J. Maciver, R. D. Michalek, and J. C. Rathmell, “Metabolic regulation of T lymphocytes,” Annual Review of Immunology, vol. 31, pp. 259–283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. L. Pearce, M. C. Walsh, P. J. Cejas et al., “Enhancing CD8 T-cell memory by modulating fatty acid metabolism,” Nature, vol. 460, no. 7251, pp. 103–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. G. J. W. van der Windt, B. Everts, C.-H. Chang et al., “Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development,” Immunity, vol. 36, no. 1, pp. 68–78, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. G. J. W. van der Windt, D. O'Sullivan, B. Everts et al., “CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 35, pp. 14336–14341, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. P. M. Gubser, G. R. Bantug, L. Razik et al., “Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch,” Nature Immunology, vol. 14, pp. 1064–1072, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Sukumar, J. Liu, Y. Ji et al., “Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function,” The Journal of Clinical Investigation, vol. 123, no. 10, pp. 4479–4488, 2013. View at Publisher · View at Google Scholar
  41. D. O'Sullivan, G. J. van der Windt, S. C. Huang et al., “Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development,” Immunity, vol. 41, pp. 75–88, 2014. View at Google Scholar
  42. E. V. Dang, J. Barbi, H.-Y. Yang et al., “Control of TH17/Treg balance by hypoxia-inducible factor 1,” Cell, vol. 146, no. 5, pp. 772–784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Z. Shi, R. Wang, G. Huang et al., “HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells,” The Journal of Experimental Medicine, vol. 208, no. 7, pp. 1367–1376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. D. Michalek, V. A. Gerriets, S. R. Jacobs et al., “Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets,” Journal of Immunology, vol. 186, no. 6, pp. 3299–3303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Yang, H. Fujii, S. V. Mohan, J. J. Goronzy, and C. M. Weyand, “Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells,” The Journal of Experimental Medicine, vol. 210, pp. 2119–2134, 2013. View at Google Scholar
  46. F. J. Dufort, B. F. Bleiman, M. R. Gumina et al., “Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism,” Journal of Immunology, vol. 179, no. 8, pp. 4953–4957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. C. A. Doughty, B. F. Bleiman, D. J. Wagner et al., “Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth,” Blood, vol. 107, no. 11, pp. 4458–4465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Caro-Maldonado, R. Wang, A. G. Nichols et al., “Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells,” Journal of Immunology, vol. 192, pp. 3626–3636, 2014. View at Google Scholar
  49. F. J. Dufort, M. Gumina, N. L. Ta et al., “Glucose-dependent de novo Lipogenesis in B Lymphocytes: a requirement for ATP-citrate lyase in LPS-induced differentiation,” The Journal of Biological Chemistry, 2014. View at Publisher · View at Google Scholar
  50. L. Oliva and S. Cenci, “Autophagy in plasma cell pathophysiology,” Frontiers in Immunology, vol. 5, article 103, 2014. View at Google Scholar
  51. U. Schenk, A. M. Westendorf, E. Radaelli et al., “Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels,” Science Signaling, vol. 1, no. 39, article ra6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Woehrle, L. Yip, A. Elkhal et al., “Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse,” Blood, vol. 116, no. 18, pp. 3475–3484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Yip, T. Woehrle, R. Corriden et al., “Autocrine regulation of T-cell activation by ATP release and P2X7 receptors,” The FASEB Journal, vol. 23, no. 6, pp. 1685–1693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Filippini, R. E. Taffs, and M. V. Sitkovsky, “Extracellular ATP in T-lymphocyte activation: possible role in effector functions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 21, pp. 8267–8271, 1990. View at Publisher · View at Google Scholar · View at Scopus
  55. G. G. Yegutkin, “Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade,” Biochimica et Biophysica Acta, vol. 1783, no. 5, pp. 673–694, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Burnstock, “Purinergic signalling—an overview,” Novartis Foundation symposium, vol. 276, pp. 26–281, 2006. View at Google Scholar
  57. M. Idzko, D. Ferrari, and H. K. Eltzschig, “Nucleotide signalling during inflammation,” Nature, vol. 509, pp. 310–317, 2014. View at Google Scholar
  58. U. Schenk, M. Frascoli, M. Proietti et al., “ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors,” Science Signaling, vol. 4, no. 162, p. ra12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Schena, S. Volpi, C. Faliti et al., “Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity,” Cell Reports, vol. 3, no. 6, pp. 1824–1831, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. M. Johnson, M. E. North, G. L. Asherson, J. Allsop, R. W. Watts, and A. D. Webster, “Lymphocyte purine 5' nucleotidase deficiency in primary hypogammaglobulinaemia,” The Lancet, vol. 1, no. 8004, pp. 168–170, 1977. View at Google Scholar · View at Scopus
  61. N. L. Edwards, D. B. Magilavy, J. T. Cassidy, and I. H. Fox, “Lymphocyte ecto-5′-nucleotidase deficiency in agammaglobulinemia,” Science, vol. 201, no. 4356, pp. 628–630, 1978. View at Publisher · View at Google Scholar · View at Scopus
  62. F. P. Bernier, A. Boneh, X. Dennett, C. W. Chow, M. A. Cleary, and D. R. Thorburn, “Diagnostic criteria for respiratory chain disorders in adults and children,” Neurology, vol. 59, no. 9, pp. 1406–1411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. U. A. Walker, S. Collins, and E. Byrne, “Respiratory chain encephalomyopathies: a diagnostic classification,” European Neurology, vol. 36, no. 5, pp. 260–267, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Morava, L. van den Heuvel, F. Hol et al., “Mitochondrial disease criteria: diagnostic applications in children,” Neurology, vol. 67, no. 10, pp. 1823–1826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Lagresle-Peyrou, E. M. Six, C. Picard et al., “Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness,” Nature Genetics, vol. 41, no. 1, pp. 106–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. L. A. Henderson, F. Frugoni, G. Hopkins et al., “First reported case of Omenn syndrome in a patient with reticular dysgenesis,” Journal of Allergy and Clinical Immunology, vol. 131, no. 4, pp. 1227–1230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. A. de La Fuente, M. Recher, N. L. Rider et al., “Reduced thymic output, cell cycle abnormalities, and increased apoptosis of T lymphocytes in patients with cartilage-hair hypoplasia,” Journal of Allergy and Clinical Immunology, vol. 128, no. 1, pp. 139–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. J. L. Jefferies, “Barth syndrome,” The American Journal of Medical Genetics C: Seminars in Medical Genetics, vol. 163, no. 3, pp. 198–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Garone, S. Tadesse, and M. Hirano, “Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy,” Brain, vol. 134, no. 11, pp. 3326–3332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. D. Gessner, M. B. Gillingham, T. Wood, and D. M. Koeller, “Association of a genetic variant of carnitine palmitoyltransferase 1A with infections in Alaska Native children,” Journal of Pediatrics, vol. 163, pp. 1716–1721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. J. R. Reichenbach, R. Schubert, R. Horvàth et al., “Fatal neonatal-onset mitochondrial respiratory chain disease with T cell immunodeficiency,” Pediatric Research, vol. 60, no. 3, pp. 321–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. A. Walker, N. Slate, A. Alejos et al., “Predisposition to infection and SIRS in mitochondrial disorders: 8 years' experience in an academic center,” Journal of Allergy and Clinical Immunology, vol. 2, no. 4, pp. 465–468, 2014. View at Publisher · View at Google Scholar
  73. J.-P. Bonnefont, F. Djouadi, C. Prip-Buus, S. Gobin, A. Munnich, and J. Bastin, “Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects,” Molecular Aspects of Medicine, vol. 25, no. 5-6, pp. 495–520, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/ SIS international sepsis definitions conference,” Critical Care Medicine, vol. 31, no. 4, pp. 1250–1256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Wagner, J. Bonhoeffer, T. O. Erb et al., “Prospective study on central venous line associated bloodstream infections,” Archives of Disease in Childhood, vol. 96, no. 9, pp. 827–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. J. R. Bach, R. Rajaraman, F. Ballanger et al., “Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates,” The American Journal of Physical Medicine and Rehabilitation, vol. 77, no. 1, pp. 8–19, 1998. View at Publisher · View at Google Scholar · View at Scopus